美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
JANUMET	022044	001	NDA	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	500MG;EQ 50MG BASE	Yes	No	2007/03/30	2007/03/30	MSD SUB MERCK	Prescription
JANUMET	022044	002	NDA	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	1GM;EQ 50MG BASE	Yes	Yes	2007/03/30	2007/03/30	MSD SUB MERCK	Prescription
JANUMET XR	202270	001	NDA	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	TABLET, EXTENDED RELEASE;ORAL	500MG;EQ 50MG BASE	Yes	No	2012/02/02	2012/02/02	MSD SUB MERCK	Prescription
JANUMET XR	202270	002	NDA	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	TABLET, EXTENDED RELEASE;ORAL	1GM;EQ 50MG BASE	Yes	No	2012/02/02	2012/02/02	MSD SUB MERCK	Prescription
JANUMET XR	202270	003	NDA	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	TABLET, EXTENDED RELEASE;ORAL	1GM;EQ 100MG BASE	Yes	Yes	2012/02/02	2012/02/02	MSD SUB MERCK	Prescription